Phathom Pharmaceuticals Inc
NASDAQ:PHAT 3:59:53 PM EDT
Earnings Announcements
Phathom Pharmaceuticals Reports First Quarter 2022 Results
Published: 05/10/2022 12:15 GMT
Phathom Pharmaceuticals Inc (PHAT) - Phathom Pharmaceuticals Reports First Quarter 2022 Results and Provides Recent Clinical, Regulatory, and Business Updates.
Revenue is expected to be $1.06 Million
Adjusted EPS is expected to be -$1.02
Next Quarter Revenue Guidance is expected to be $1.95 Million
Next Quarter EPS Guidance is expected to be -$1.09
More details on our Analysts Page.
Adjusted EPS is expected to be -$1.02
Next Quarter Revenue Guidance is expected to be $1.95 Million
Next Quarter EPS Guidance is expected to be -$1.09
More details on our Analysts Page.